Hand holding the newspaper resting on a table with a cup of coffee

Newsroom

Taxonomy Icon
  • April 10, 2019
  • Source: Healio | HemOnc Today
Ivy Brain Tumor Center at The Barrow Neurological Institute has launched a program that offers phase 0 trials to accelerate the drug approval process for patients with glioblastoma.
Taxonomy Icon
  • April 8, 2019
  • Source: The Onco'Zine Brief
In this edition of The Onco’Zine Brief Peter Hofland talks with Dr. Nader Sanai an internationally-recognized neurosurgical oncologist with clinical and research expertise in the treatment of all brain tumors, including glioblastoma, the most aggressive cancer that begins within the brain.
Taxonomy Icon
  • March 27, 2019
  • Source: Scientific American
In Bret Stetka's latest piece for the Scientific American, Dr. Nader Sanai weighs in on the challenges of treating glioblastoma and how our accelerated Phase 0/2 clinical trials are delivering new therapeutic options for patients facing the fight of their lives.
Taxonomy Icon
  • January 21, 2019
  • Source: KGUN 9
The Ivy Brain Tumor Center at Barrow Neurological Institute is taking a bold approach by using Phase 0 testing in patient clinical trials.
Taxonomy Icon
  • January 21, 2019
  • Source: ABC15
There's a glimmer of hope in treating the deadliest form of brain cancer, thanks to a drug trial happening right here in the Valley.
Taxonomy Icon
  • November 28, 2018
  • Source: Texoma's | KFDX 3
Senator John McCain recently died after fighting glioblastoma, the most aggressive and deadliest kind of brain tumor. Now, other patients whose brain tumors come back have a revolutionary new option for treatment.
Taxonomy Icon
  • November 27, 2018
A new Ivy Brain Tumor Center study finds that recently-approved drug ribociclib may be an important part of treatment for glioblastoma, one of the deadliest cancers in the world.
Taxonomy Icon
  • November 25, 2018
  • Source: The ASCO Post
The Ben and Catherine Ivy Foundation, in partnership with the Barrow Neurological Institute in Phoenix, has awarded a $50 million grant to establish a new translational science program focusing on early-phase, pharmacodynamic- and pharmacokinetic-driven clinical trials for aggressive brain tumors.
Taxonomy Icon
  • November 8, 2018
  • Source: WNDU | 16 News Now
In the last 30 years, a brain tumor expert says median survival has only increased by a few months. Now, a new brain tumor center program is fast-tracking patients into new therapies.
Taxonomy Icon
  • September 10, 2018
  • Source: Phoenix Business Journal
Thanks to a $50 million grant, Barrow Neurological Institute will create a new center to focus on finding a cure and improving outcomes for the deadliest form of brain cancer.